Parenteral Use of Ghrelin Inverse Agonists in Obesity Associated Metabolic Disorders

• Unité de recherche: INNOSUISSE
• Numéro de projet: 18012.1 PFLS-LS
• Titre du projet anglais: Parenteral Use of Ghrelin Inverse Agonists in Obesity Associated Metabolic Disorders

Description succincte (Allemand)

Parenteral Use of Ghrelin Inverse Agonists in Obesity Associated Metabolic Disorders

Description succincte (Anglais)

Parenteral Use of Ghrelin Inverse Agonists in Obesity Associated Metabolic Disorders

Résumé des résultats (Abstract) (Allemand)

This follow-up project aims at optimizing existing small molecule lead series previously designed as potent and selective inverse agonists of the ghrelin receptor. The ultimate goal is to obtain preclinical drug candidates for the development of an innovative parenteral therapy of obesity linked with type 2 diabetes or other metabolic syndromes.

Résumé des résultats (Abstract) (Anglais)